依达拉奉联合奥扎格雷钠治疗急性脑梗死的TCD观察  

Edaravone in joint Ozagrel Sodiumin the treatment of acute cerebral infarction TCD observation

作　　者：赵玲[1] 黄友荣[1] 

机构地区：[1]山东省滕州市中心人民医院功能检查科,277500

出　　处：《中国实用医药》2012年第14期145-146,共2页China Practical Medicine

摘　　要：目的应用TCD观察依达拉奉联合奥扎格雷钠治疗急性脑梗死(ACI)与单用奥扎格雷钠血流动力学变化的差别。方法 80例住院患者随机分成治疗组(40例)和对照组(40例)。两组治疗前、治疗后14d应用TCD观察大脑中动脉(MCA)血流动力学变化,并进行对比研究。结果两组比较有显著性差异(P<0.01)。治疗组的血流动力学变化明显优于对照组。结论通过应用TCD,为指导临床治疗和评估疗效提供了有力的依据。Objective Observe Edaravone in combination with those of Ozagrel Sodiumin the treatment of acute cerebral infarction hemodynamics changes difference.Methods Within 48 hours of the ACT in 80 cases,randomly divided into treatment group（n=40） and control group（n = 40）.To observe the hemodynamics changes before and after the treatment,and analyze the results.Results There was a markedly difference between the two groups（P〈0.01）.The Treatment group were superior to control group,and symptoms disappeared earlyer than control group.Conclusion The technology of TCD can provide a new indicutor for clinic selection of reasonable treatment and evaluation of effect.

关 键 词：依达拉奉 奥扎格雷钠 急性脑梗死 TCD 血流动力学 

分 类 号：R743.3[医药卫生—神经病学与精神病学]